SCHEMBL9498643

SCHEMBL9498643

CC(N)C(=O)N[C@H]1CC[C@@H](CO[N+](=O)[O-])CC1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.40
SMYD3 Q9H7B4 4/20 0.38
XIAP P98170 2/20 0.34
LMNA P02545 1/20 0.33
BLM P54132 1/20 0.33
SLC1A3 P43003 2/20 0.33
SLC1A2 P43004 2/20 0.33
SLC1A1 P43005 2/20 0.33
ACACB O00763 1/20 0.32
ARG1 P05089 1/20 0.32
ARG2 P78540 1/20 0.32
EPHX2 P34913 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
ALDH1A1 P00352 1/20 0.31
TMEM97 Q5BJF2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9501675 1.00 KMT2A (0.40) KMT2ASMYD3XIAPLMNABLM
SCHEMBL9497748 0.79 SMYD3 (0.39) KMT2ASMYD3XIAPLMNABLM
SCHEMBL9499642 0.79 SMYD3 (0.39) KMT2ASMYD3XIAPLMNABLM
SCHEMBL9795289 0.79 SMYD3 (0.39) KMT2ASMYD3XIAPLMNABLM
SCHEMBL9795380 0.79 ALDH1A1 (0.38) KMT2ASMYD3LMNASMN1; SMN2L3MBTL1
SCHEMBL9499613 0.79 DRD2 (0.31) SMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL9795454 0.79 DRD2 (0.31) SMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL22987448 0.78
SCHEMBL3562819 0.78
SCHEMBL2156256 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0367019-B1 PHARMACEUTICAL COMPOSITIONS CONTAINING NITROXYALKYL AMINE WITH AN AMIDE FUNCTION, AND METHOD FOR THE PREPARATION OF THE COMPOUNDS Roche Diagnostics GmbH (DE) 1993-05-12 EP disclosed
EP-0367019-A1 Pharmaceutical compositions containing nitroxyalkyl amine with an amide function, and method for the preparation of the compounds Roche Diagnostics GmbH (DE) 1990-05-09 EP disclosed